Integrated Diagnostics (OTCMKTS:IDGXF – Get Free Report) will likely be releasing its resultson Wednesday, June 3rd. Analysts expect Integrated Diagnostics to post earnings of ($0.0112) per share and revenue of $102.7020 million for the quarter.
Integrated Diagnostics Stock Performance
Shares of OTCMKTS:IDGXF opened at $0.59 on Wednesday. Integrated Diagnostics has a 52-week low of $0.45 and a 52-week high of $0.70. The business has a 50-day moving average price of $0.63 and a 200-day moving average price of $0.64.
Integrated Diagnostics Company Profile
Integrated Diagnostics Holdings PSC (OTCMKTS: IDGXF) is a leading provider of diagnostic services in the United Arab Emirates and the broader Gulf Cooperation Council (GCC) region. Headquartered in Abu Dhabi, the company operates an extensive network of pathology laboratories and radiology facilities, offering a comprehensive suite of clinical testing and medical imaging services. Its offerings span routine laboratory tests, advanced molecular diagnostics, histopathology, and a range of radiological modalities such as MRI, CT, ultrasound, and X-ray.
Since its founding in 1993, Integrated Diagnostics has expanded its footprint across the UAE, with patient service centers and lab collection points in Abu Dhabi, Dubai, and the Northern Emirates.
Featured Stories
- Five stocks we like better than Integrated Diagnostics
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
